BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35615794)

  • 1. [The IL-6/STAT3 signaling pathway mediated by radiotherapy regulates the expression of PD-L1 in esophageal cancer cells].
    Zhou YC; Pang XZ; Zhu HL; He Y; Shen Y; Ma DY
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):389-394. PubMed ID: 35615794
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines].
    Wang J; Sun Z; Yu J; Sun S
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):575-81. PubMed ID: 25430022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
    Chen X; Wang L; Wang W; Zhao L; Shan B
    Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
    Bai YD; Shi ML; Li SQ; Wang XL; Peng JJ; Zhou DJ; Sun FF; Li H; Wang C; Du M; Zhang T; Li D
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):117-128. PubMed ID: 36781232
    [No Abstract]   [Full Text] [Related]  

  • 6. Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A/JAK/STAT3 Signaling Pathway.
    Liu C; Ji J; Li C
    Am J Chin Med; 2024; 52(1):275-289. PubMed ID: 38291583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway.
    Ren D; Zhao J; Sun Y; Li D; Meng Z; Wang B; Fan P; Liu Z; Jin X; Wu H
    J Exp Clin Cancer Res; 2019 Dec; 38(1):485. PubMed ID: 31818309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.
    Zhang GQ; Jiao Q; Shen CT; Song HJ; Zhang HZ; Qiu ZL; Luo QY
    Cancer Sci; 2021 Mar; 112(3):997-1010. PubMed ID: 33247999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
    Zhu ZQ; Hu HF; Zheng XY; Wang F
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
    [No Abstract]   [Full Text] [Related]  

  • 10. Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21.
    Wang H; Qi Y; Lan Z; Liu Q; Xu J; Zhu M; Yang T; Shi R; Gao S; Liang G
    Gene Ther; 2023 Feb; 30(1-2):88-100. PubMed ID: 35440807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.
    Xu L; Chen X; Shen M; Yang DR; Fang L; Weng G; Tsai Y; Keng PC; Chen Y; Lee SO
    Mol Oncol; 2018 Mar; 12(3):269-286. PubMed ID: 28865178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling.
    Ju X; Zhang H; Zhou Z; Chen M; Wang Q
    Exp Cell Res; 2020 Nov; 396(2):112315. PubMed ID: 33031808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.
    Horlad H; Ma C; Yano H; Pan C; Ohnishi K; Fujiwara Y; Endo S; Kikukawa Y; Okuno Y; Matsuoka M; Takeya M; Komohara Y
    Cancer Sci; 2016 Nov; 107(11):1696-1704. PubMed ID: 27564404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NME4 modulates PD-L1 expression via the STAT3 signaling pathway in squamous cell carcinoma.
    Zheng S; Liu Q; Liu T; Yang L; Zhang Q; Shen T; Zhang X; Han X; Lu X
    Biochem Biophys Res Commun; 2020 May; 526(1):29-34. PubMed ID: 32192776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP8 activates STAT3 to induce PD-L1 expression in osteosarcoma.
    Zheng S; Wei Y; Jiang Y; Hao Y
    Tumori; 2021 Jun; 107(3):238-246. PubMed ID: 33054597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of STAT3/PD-L1 and Activation of miR193a-5p Are Critically Involved in Apoptotic Effect of Compound K in Prostate Cancer Cells.
    Lee JH; Lee DY; Lee HJ; Im E; Sim DY; Park JE; Park WY; Shim BS; Kim SH
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of miR-146a on biological behavior of esophageal squamous cell carcinoma cells and its mechanism].
    Xie WY; Yang S
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):912-918. PubMed ID: 33256301
    [No Abstract]   [Full Text] [Related]  

  • 20. B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
    Li L; Zhang J; Chen J; Xu-Monette ZY; Miao Y; Xiao M; Young KH; Wang S; Medeiros LJ; Wang M; Ford RJ; Pham LV
    Blood; 2018 Oct; 132(17):1805-1817. PubMed ID: 30209121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.